TABLET LOSARTAN CHLORTHALIDONE and other medicines

Bid document / publication date

Bid document GEM/2026/B/7835267 is dated 10-08-2026.

• This is the printed bid-document date; no separate NIT publication timestamp is printed elsewhere in the pack.

Bid end and bid opening (as printed; later date corrigenda issued)

Printed bid end is 31-08-2026 17:00:00 and bid opening 31-08-2026 17:30:00; later Date corrigenda were issued, but the available corrigendum PDF does not restate new end/opening timestamps.

• Original printed values: Bid End Date/Time 31-08-2026 17:00:00; Bid Opening Date/Time 31-08-2026 17:30:00.
• Corrigendum GEM/2026/B/7835267-C5 is itself dated 03-09-2026 (after the printed original end date) and restates Buyer ATC; it does not print a revised bid end or opening clock time.
• Other Date-type corrigenda in the pack have no PDF body with revised calendar times, so the final portal end/opening timestamps are not verifiable from the available document files.
• Auto-extension rule on the bid: minimum 3 bids to disable auto extension; auto-extend by 7 days; Number of Auto Extension count = 1.

Bid offer validity

Bid offer validity is 180 days from the bid end date.

• No corrigendum in the pack amends the 180-day validity figure.

Pre-bid / clarification window

No separate pre-bid meeting date is fixed; bidders must use the GeM Representation/Clarifications window during the bidding period, and technical clarifications during evaluation are allowed for 7 days.

• ATC: Representation/Clarifications window on GeM is to be used; buyer may not address clarifications outside GeM beyond the prescribed time.
• Bid details: Time allowed for Technical Clarifications during technical evaluation = 7 Days.

Delivery / completion timeline

Consignee-wise delivery period is 90 days for every schedule; contractual delivery runs from the priced Purchase Order effective date and delivery date is essence of the contract.

• BOQ sheet and bid consignee tables show Delivery Period 90 days for all 11 items to RAPS Hospital, Rawatbhata.
• ATC: Contract comes into force from date of issue of priced Purchase Order (Effective Date); CDD reckoned from that date.
• Compliance sheet: supply in a single lot not later than as mentioned in the bid from the date of the Purchase Order.

Estimated / tender value

No numerical estimated bid value, tender cost or total project value is printed in the available documents.

• Bid text refers generically to 'Estimated Bid Value indicated above' for guidance on EMD/eligibility, but no amount is shown in the bid extract.
• EMD and ePBG are both marked Not Required, consistent with absence of a stated EMD amount.

EMD / bid security and performance security

EMD is not required and ePBG/performance security is not required for this bid.

• EMD Detail — Required: No.
• ePBG Detail — Required: No.
• MSE undertaking format still mentions dealers must pay requisite EMD if EMD is stipulated; here EMD is not required.
• GTC still defines Bid Security and Performance Security instruments generally, but this bid switches both off.

Tender document / bid fee

No tender document fee or bid participation fee is stipulated; GeM disclaimer treats asking for tender/bid participation fee as an invalid ATC practice.

Payment terms

100% payment within 10 days of CRAC and online bill submission; TReDS is the preferred payment mode for MSME sellers; payment supporting documents must go to the Paying Authority immediately after dispatch.

• Bid Payment Timelines: within 10 days of issue of CRAC and on-line submission of bills (stated as supersession of GeM GTC clause 12's 10 days — same outer period).
• GTC default for goods is also 100% within ten (10) days of CRAC and online invoice.
• TReDS preferred mode; NPCIL registered on RXIL; seller and buyer both need TReDS registration for factoring.
• Post-dispatch documents to Paying Authority: Original invoice (Bill to / Shipped to), Annexure-F, Seller bank details, E-invoice if applicable, Test certificate if applicable — late documents may lead to rejection of supplies.
• GST: bidder to check applicable GST; reimbursement lower of actuals or applicable rates, capped at quoted GST%; GST invoice + GST portal payment screenshot required on GeM invoicing.

Quantity option, variation and purchase preference economics

Purchaser may vary order quantity by up to ±25% under the option clause; line-item packing variation ±5% is accepted; MSE purchase preference applies within L1+15% for up to 25% quantity; MII preference is off.

• Option clause: increase/decrease up to 25% of bid quantity at placement and up to 25% of contracted quantity during currency at contracted rates; extra delivery time formula applies (min 30 days unless original DP < 30).
• Compliance sheet quantity variation ±5% line-item-wise due to odd size packing treated as completed supply.
• MSE Purchase Preference: Yes; band L1+15%; max 25% of bid quantity for MSE OEMs/service providers; traders/resellers excluded from MSE benefits.
• MII Purchase Preference: No.
• Item-wise evaluation / schedule-wise L1 award.

Manufacturer / authorised channel only

Only the manufacturer or authorised re-sellers/distributors/dealers/agents for the particular drugs/medicines may bid; non-manufacturers must upload the manufacturer's authorisation with the bid.

• Restated in Corrigendum C5 ATC clause 11 and in BOQ Compliance Sheet item 1.

GMP and drug-licence quality credentials

The pharmaceutical company must hold a current valid GMP certificate from state/central drug control authorities, with documentary evidence uploaded with the bid.

• Private drug manufacturers must also submit a notarised undertaking (Rs 10 non-judicial stamp) covering manufacture, D&C Act licence and SUGAM portal upload under rule 84AB.

Experience / turnover criteria and MSE-Startup relaxations

The bid enables complete MSE and Startup relaxation from years-of-experience and turnover, but no numeric experience years, bidder turnover or OEM average turnover thresholds are actually printed in the documents.

• MSE Relaxation for Years Of Experience and Turnover: Yes | Complete.
• Startup Relaxation for Years Of Experience and Turnover: Yes | Complete.
• Standard GeM relaxation text refers to Experience Criteria / Bidder Turnover / OEM Average Turnover 'as defined above', yet no amounts or years appear above that text.
• Any bidder seeking exemption must still upload supporting MSE/Startup documents for buyer evaluation.

MSE purchase-preference eligibility (manufacturers only)

MSE purchase preference is available only to manufacturers/OEMs of the offered product with valid online-validated Udyam credentials; dealers/distributors/traders/stockists are excluded from MSE benefits.

• If seeking MSE benefits, submit ATC MSE Benefits declaration plus Udyam Registration Certificate (Additional Doc-2).
• Benefits allowed only if seller is validated online in GeM profile and approved by Buyer after document evaluation.
• If L1 is not MSE and MSE quote is within L1+15%, opportunity to match L1 for 25% quantity.

One-bid-per-bidder, land-border and banning / debarment

Only one bid per bidder (GeM GTC clause 29) is allowed; land-border bidders need Competent Authority registration; NPCIL-banned firms and allied firms are barred and bids are summarily rejected.

• Annexure-D undertaking on company letterhead is mandatory (Additional Doc-1) confirming single bid and no sister/allied participation.
• GTC clause 26 land-border restriction is expressly applied on the bid closing page.
• NPCIL banning period: not less than 6 months and not exceeding 2 years; extends to allied firms/JV partners; independent of GeM IM policy.
• Grounds include cartelisation, false documents, counterfeit supply, code-of-integrity breaches, withdrawal after becoming successful without cause, etc.
• Prior debarment/transgression disclosure obligations appear in the banning annex code-of-integrity section.

Consortium / JV

No consortium or JV participation structure, equity floor or member-cap is prescribed for this goods bid; banning rules still treat JV/consortium partners as jointly affected if banned.

• No affirmative JV/consortium bidding permission appears in the bid or ATC.
• Annexure-II states if a JV/consortium is banned, all partners stand debarred for the banning period.

What is being procured

Supply-only procurement of 11 pharmaceutical items (tablets, liquids, respules, inhaler, injections, creams) for RAPS Hospital under BOQ title TABLET LOSARTAN CHLORTHALIDONE and other medicines; total quantity 15,570 units across schedules.

• Scope of supply: Only supply of Goods; bid price to include all cost components.
• Organisation: Nuclear Power Corporation of India Limited, Rawatbhata Rajasthan Site / Department of Atomic Energy.
• Item-wise evaluation with 11 schedules; L1 decided separately per schedule.

Items, strengths, quantities and UOMs

Eleven line items with specified strengths/pack sizes and quantities, all deliverable in 90 days to one consignee.

• 1. Tablet Losartan + Chlorthalidone 50+6.25 mg — 400 TABLET
• 2. Tablet Olanzapine 2.5 mg — 1000 TABLET
• 3. Liquid Povidone Iodine 1% 100 ml — 800 BOTTLE
• 4. Liquid Chlorhexidine Gluconate 0.2% + Sodium Fluoride + Zinc Chloride + Cetrimide + Triclosan 100 ml — 5000 BOTTLE
• 5. Respule Salbutamol 2.5 ml — 2000 RESPULES
• 6. Inhaler Tiotropium 120 MDI — 100 INHALER
• 7. Respules Levosalbutamol 1.25 mg/2.5 ml — 5000 RESPULES
• 8. Injection Moxifloxacin 400 mg — 200 INJECTION
• 9. Injection Erythropoietin 5000 IU — 20 INJECTION
• 10. Cream Silver Sulphadiazine 500 gm — 50 TUBE
• 11. Cream Beclomethasone 15 gm — 1000 TUBE

Delivery location and logistics constraints

Single consignee: Ninad Silvester Kantela, Contracts & Material Management, RAPS Hospital, PO-Bhabha Nagar, Rawatbhata, Via-Kota, Rajasthan 323307 (~50 km from Kota); plant gate access only 09:00–15:00 on working days with specified vehicle/driver documents.

• Supplier should intimate consignee email (as in GeM contract) with driver/helper details one or more days before arrival for gate pass.
• Driver documents: original Aadhaar, heavy-duty licence if applicable, RC, fitness, road tax, insurance, LR with invoice/challan.
• Cold chain to be maintained whenever applicable.
• Each carton/container/strip/bottle etc. must be embossed/stamped 'RAPS HOSPITAL SUPPLY - NOT FOR SALE' at contractor cost.

Quality, shelf-life, ATR and rejection/replacement rules

ATR must accompany supply; manufacturing age at supply ≤ 6 months; prefer latest single batch with minimum 3-year shelf life, with free replacement/credit-note rules for short-shelf or near-expiry stock; non-conforming or damaged packs are rejected and replaced free of cost.

• Medicines not as per ATR, or with damaged/broken packing, rejected and replaced free of cost.
• If short shelf life supplied and full quantity cannot be used before expiry, replace free of cost; medicines with ≥3 years shelf life also to be replaced before expiry with fresh stock or refund via credit note adjusted in future supplies.
• Seller's Declaration: supply strictly as per buyer's technical specifications with no deviation.
• Inspection Required: No (no empanelled inspection authority mandated at bid stage).

Submission mode and bid structure

Online two-packet bid on GeM; upload all certificates/documents sought in the bid, ATC and corrigendum with the bid — missing uploads make the offer liable to rejection.

• Type of Bid: Two Packet Bid.
• Documents required from seller listed as Additional Docs 1–4 (Requested in ATC).
• Documents not submitted with the bid, and clarifications sought at evaluation but only furnished later during representation, shall not be considered for evaluation.
• No physical-original pre-requisite is mandated for qualification (GeM disclaimer treats mandating physical docs other than EMD/Integrity Pact within 5 days of opening as invalid ATC).
• Price bid / SOQR mismatch rules in Annexure-I (ATC annex) govern financial evaluation; unauthorised SOQR changes or missing break-up can reject the bid.
• GeM seller DSC/e-sign process is governed by GeM portal/GTC; no special Class of DSC is separately prescribed in the bid ATC.

Signing / attestation mechanics

ATC formats require authorised signatory signature and company seal; Annexure-D on company letterhead; private-manufacturer undertaking on Rs 10 notarised stamp paper; Compliance Sheet needs stamp and signature with Yes/No against each point.

• Mandate Form: authorised sign. with seal, addressed to Manager (Finance & Accounts), Rawatbhata Rajasthan Site; attach cancelled cheque for bank account.
• Compliance Sheet note: compliance must be clearly Yes or No for each point, else offer ignored for further evaluation.

Date corrigenda chain (portal date extensions)

Multiple Date-type corrigenda were issued after the original printed bid end of 31-08-2026; the only corrigendum PDF in the pack (C5 dated 03-09-2026) does not print revised bid end/opening clock times.

• Original printed bid end/opening: 31-08-2026 17:00:00 / 31-08-2026 17:30:00.
• Available document pack contains Corrigendum GEM/2026/B/7835267-C5 dated 03-09-2026 (after original end date), confirming the bid remained live for ATC restatement after 31-08-2026.
• No corrigendum PDF in the pack reprints a superseding Bid End Date/Time or Bid Opening Date/Time; bidders must read the live GeM bid header for the final clock times.
• Bid offer validity figure (180 days from end date) is not amended in C5.

Corrigendum C5 — full restatement of Buyer ATC + new AMRCD clause

C5 supersedes all existing Buyer-added Bid Specific Terms and any previous corrigendum ATC, restates the operational ATC (option clause, documents, MSE, LD waiver, plant entry, TReDS, manufacturer eligibility) and newly adds AMRCD dispute resolution as ATC clause 12.

• Impact: bidders must follow C5 text + uploaded ATC annex, not earlier ATC-only wording where they differ.
• Substantive addition vs original bid ATC text: Clause 12 AMRCD for CPSE/Port Authority/Govt Department commercial-contract disputes per DPE OM No. DPE-02/0001/2023-AMRCD-FTS-13578 dt. 8th December, 2025; AMRCD decision binding.
• Original bid details still show Arbitration Clause: No and Mediation Clause: No — C5 does not flip those flags to Yes, but adds AMRCD for the covered public-sector dispute class.
• LD waiver (GeM GTC 15(iii) not applicable), manufacturer-only channel rule, Additional Docs 1–4, payment document pack, and option clause ±25% are restated unchanged in substance.
• Action for bidder: re-read C5 before submission; ensure Annexure-D/F/Mandate/Compliance uploads; note AMRCD if bidder is a CPSE counterparty scenario; ignore any superseded prior ATC PDF versions.

Values that finally apply after corrigenda

Final operative commercial/ATC position: C5 Buyer ATC + annex formats; EMD/ePBG still not required; 180-day offer validity; 90-day delivery; LD under GTC 15(iii) waived; MSE preference on; MII off; manufacturer/authorised channel + GMP; AMRCD added; final bid end/opening clock times not printed in corrigendum PDFs.

• Financial securities: EMD Required No; ePBG Required No (unchanged from original bid details).
• Payment: within 10 days of CRAC + online bills; TReDS preferred for MSME.
• Quantity: option ±25%; packing variation ±5% line-item-wise.
• Evaluation: item/schedule-wise L1.
• Documents: Additional Docs 1–4 + GMP + authorisation if reseller + private-manufacturer notarised undertaking if applicable.
• Scope unchanged: 11 medicine schedules, total qty 15570, consignee RAPS Hospital Rawatbhata.

Printed bid end 31-08-2026 vs later-dated corrigendum without new times

Original bid prints end/opening on 31-08-2026, yet Corrigendum C5 is dated 03-09-2026 and prior Date corrigenda exist, without any PDF restating the superseding end/opening timestamps.

• Side A — Bid document p.1: Bid End 31-08-2026 17:00:00; Opening 31-08-2026 17:30:00.
• Side B — Corrigendum C5 dated 03-09-2026 continues the bid with full ATC restatement after that printed end date, but prints no new end/opening.
• What prevails for calendar times: live GeM bid header after Date corrigenda (not printable from this pack); for ATC content, C5 overwrites prior Buyer ATC.
• Bidder action: do not rely on 31-08-2026 from the static PDF alone.

Two different 'Annexure-I' labels

Buyer ATC Annexure-I is the Price Break-up/SOQR evaluation rules, while the BOQ specification PDF also titles its Compliance Sheet as Annexure-I — same label, different instruments.

• Side A — ATC annex Annexure-I: PRICE BREAK-UP / SOQR mismatch rules for financial evaluation.
• Side B — BOQ PDF Annexure-I: COMPLIANCE SHEET of technical/commercial medicine conditions (GMP, shelf life, stamping, etc.).
• What prevails: both apply to their own subject-matter; do not confuse the price Annexure-I with the compliance Annexure-I when uploading Additional Doc-4 vs financial SOQR.

Arbitration Clause 'No' vs AMRCD clause added in C5

Bid details set Arbitration Clause and Mediation Clause to No, while Corrigendum C5 ATC clause 12 mandates AMRCD for specified CPSE/Government commercial-contract disputes.

• Side A — Bid details: Arbitration Clause No; Mediation Clause No.
• Side B — C5 ATC 12: CPSE/Port/Govt Department commercial-contract disputes (with stated exclusions) go to AMRCD; decision binding.
• What prevails: for the narrow public-sector dispute class covered by the DPE OM, C5 ATC 12 applies as the later Buyer ATC; general commercial arbitration is still not elected by the bid flags.
• Not a full reverse of 'Arbitration No' for private sellers, but a real add-on for covered public counterparties.

GeM GTC LD schedule vs ATC LD waiver

GeM GTC clause 15(iii) provides LD at 0.5%/week (caps 5%/10%), but Buyer ATC (original and C5) states that GTC 15(iii) LD shall not be applicable to contracts from this bid.

• Side A — GTC 15(iii): LD @ 0.5% of delayed quantity contract value per week, max 5% normally / 10% for inordinate delay.
• Side B — ATC clause 7: LD under GTC 15(iii) not applicable for this bid's contract.
• What prevails: ATC LD waiver for this bid (C5 restates it). Delivery period remains essence of contract and other GTC remedies may still matter — see risks.

Confirm final bid end and opening timestamps after Date corrigenda

Ask buyer to confirm the live GeM Bid End Date/Time and Bid Opening Date/Time, because the pack’s PDFs still show 31-08-2026 while C5 is dated 03-09-2026 without new clock times.

• Material to bid/no-bid timing and 180-day validity anchor date.
• Request written confirmation via GeM representation window.

Scope of LD waiver vs other delay remedies

Clarify whether waiver of GTC 15(iii) LD also bars risk purchases, short-closure, risk & cost, IM actions or withholding for delay, given delivery remains essence of contract and invoice upload is blocked after DP expiry.

• Pricing and risk contingency depend on whether delay is truly consequence-free beyond LD.

Shelf-life dual conditions for short-dated products

Confirm operability of 'manufacturing not older than 6 months at supply' together with 'minimum three years shelf life' for each of the 11 SKUs, and the exact replacement/credit-note trigger and timeline.

• Some injectables/creams may not carry 3-year dating; need buyer acceptance rule before pricing short-dated lines.

Per-schedule partial bidding and authorisation/GMP granularity

Confirm that a bidder may quote only selected schedules under item-wise evaluation, and whether separate manufacturer authorisation and GMP evidence are required for each quoted molecule/SKU.

• Affects channel partners who are authorised for only some of the 11 products.

Private-manufacturer undertaking — mandatory or optional wording

Compliance Sheet item 9 says the notarised private-manufacturer undertaking 'may be submitted' — seek confirmation whether buyer will reject private manufacturers who omit it.

• Pass/fail ambiguity on a stamped/notarised format.

Hard document cut-off and representation bar

Missing bid uploads can reject the offer; documents first produced only at representation stage after evaluation queries are ignored — no second chance to cure eligibility gaps.

• High process risk on GeM two-packet medicine bids with multiple Additional Docs.

Delivery essence, invoice lockout and plant-access friction despite LD waiver

Even with GTC 15(iii) LD waived, delivery date is essence of contract; GeM blocks invoice upload after DP expiry; Rawatbhata plant gate allows entry only 09:00–15:00 with a long original-document checklist — late or non-conforming arrivals threaten non-acceptance and payment failure.

• Option clause can add quantity with formula-based extra time (min 30 days), stretching working-capital exposure.
• Payment pack delay 'may lead to rejection of supplies' despite 10-day CRAC payment timeline.

Shelf-life, stamping, ATR and free-replacement liabilities

Seller bears ongoing free replacement/credit-note risk for short-dated or expiring stock, must stamp 'NOT FOR SALE', supply ATR, maintain cold chain where needed, and replace non-conforming/damaged goods free of cost.

• Manufacturing age ≤6 months at supply plus preference for ≥3-year dating is operationally tight for some SKUs.
• ±5% packing variation acceptance helps odd packs but does not reduce quality liabilities.

Price SOQR mismatch and retender exposure

If GeM Total Price exceeds SOQR total and seller does not cooperate in negotiation to align, the requirement will be re-tendered; mixing price into technical packet summarily rejects the bid.

• Item-wise evaluation still uses GeM Total Price logic per Annexure-I for the relevant financial packet mechanics.

NPCIL banning / integrity and land-border exposure

False declarations, cartelisation, counterfeit supply or code-of-integrity breaches can trigger 6-month to 2-year NPCIL banning (allied firms included); land-border non-compliance is ground for immediate contract termination and legal action.

• One-bid-per-bidder breach risks disqualification, EMD forfeiture (if any) and administrative action per Annexure-D/GTC 29.
• GTC LD quantum (0.5%/week, 5–10% caps) is waived here, but banning and GeM IM remain independent levers.

GST quotation and anti-profiteering certifications

Buyer takes no responsibility for GST mistakes; reimbursement is capped at quoted GST% and lower of actual/applicable rate; Annexure-F forces strong GST/TDS certifications including anti-profiteering and IMS amendments.

• Incorrect GST loading can erase margin after award.

Inviting authority / organisation

Nuclear Power Corporation of India Limited (Department of Atomic Energy / PMO), office Rajasthan — Rawatbhata Rajasthan Site / RAPS Hospital supply.

• Ministry/State Name: Pmo
• Department Name: Department Of Atomic Energy
• Organisation Name: Nuclear Power Corporation Of India Limited
• Office Name: Rajasthan
• BOQ header: RAWATBHATA RAJASTHAN SITE

Buyer and grievance email contacts

Buyer email [email protected]; HOD grievance redressal email [email protected].

• Delivery-period extension requests may also be emailed to the buyer email ID mentioned in the GeM contract.
• Representations/clarifications are to be raised on the GeM representation window, not outside GeM beyond prescribed time.

Consignee / reporting officer and delivery address

Consignee/Reporting Officer Ninad Silvester Kantela; address 323307, Contracts & Material Management, RAPS Hospital, PO-Bhabha Nagar, Rawatbhata, Via-Kota, Rajasthan (about 50 km from Kota).

• All 11 schedules ship to this single consignee location.
• Intimate dispatch to consignee email as per GeM contract before arrival.
• No separate physical bid-submission address is prescribed; bids are on GeM. Mandate Form is addressed to Manager (Finance & Accounts), Rawatbhata Rajasthan Site for bidder bank details.